Navigation Links
Biotechnology Value Fund Delivers Letter to Board of Directors of Avigen, Inc.
Date:12/11/2008

ain from voting or to vote in proportion to all other outstanding shares. This offer was not accepted. The pill should be redeemed altogether.

The Board's recent actions reveal its true self-interest and leave us concerned that Avigen will indeed destroy and/or take all remaining value. Consequently, our primary issue has been and remains that Avigen immediately guarantee the worst case outcome for all shareholders. This guarantee could be accomplished in several ways, including by dividending or otherwise distributing all excess cash to shareholders now, or by offering to buy back any and all shares from holders that wish to sell at a specific price at a specific future date (i.e., $1.25 per share in December, 2009). In both cases, shareholders could stand to reap potentially substantial upside derived from the monetization of Avigen's remaining assets and could finally stop worrying about whether the Company will destroy its substantial cash value. To the extent the Board believes it can generate value in excess of its cash in the bank today, offering downside protection ultimately costs the Company nothing. However, by rejecting our proposal to provide a downside guarantee, the Board has indicated its willingness to place its remaining cash at continued risk, without shareholder consent.

As the Company's largest shareholder, we are fighting to return value to all shareholders, not just ourselves, and we feel a responsibility to do so. To be clear, we do not seek to impose our own agenda on Avigen, we only ask that shareholders be empowered to decide the fate of the Company's residual cash, rather than the management and Board of a company which has repeatedly tried and failed to create any shareholder value whatsoever. Shareholders have good reason to worry that Avigen's management fully intends to put its remaining cash at risk. Yesterday, at the RBC Capital Markets Healthcare Conference, CEO Ken Chahine said,
'/>"/>

SOURCE Biotechnology Value Fund, L.P.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Micromet Added to NASDAQ Biotechnology Index
2. Far From Beyond: A Glimpse into the World of Biotechnology and the Future of the Free World
3. North Carolinas Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs
4. Yongye Biotechnology Announces Record Third Quarter Results
5. World Market for Biotechnology Reagents to Reach $32.5 Billion by 2012, According to New Report by Global Industry Analysts, Inc.
6. Yongye Biotechnology to Present at Roth Capital China Comes to Vegas Conference
7. InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement
8. InNexus Biotechnology Receives Patent Grants in Europe
9. InNexus Biotechnology CEO to Present at the 7th Annual BIO Investor Forum
10. TechConnect World 2009 Matches Tomorrows Technology Solutions with Todays Business Needs for Clean-Technology, Biotechnology and Nanotechnology
11. Lixte Biotechnology Holdings Announces New Appointment to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... 14 Nektar Therapeutics (Nasdaq: NKTR ... appointed to serve on its board of directors. ... with over 35 years of experience in corporate ... to Nektar extensive industry perspective at an important ... Robin, President and CEO of Nektar and member ...
(Date:12/14/2009)... - Results From a Survey Conducted by UCB Assessing ... Countries , , - A third of ... impacts their enjoyment of the festive season, ... shopping for gifts, preparing holiday ... difficult to do, - Nearly ...
(Date:12/11/2009)... miRagen Therapeutics, Inc., a biopharmaceutical company focused ... therapeutics for cardiovascular and muscle disease, today announced ... plays a crucial role in the progression of ... and in neuromuscular synaptic regeneration in mice. ... of the journal Science , reveal miR-206 ...
(Date:12/11/2009)... Dec. 11 Ambit Biosciences Corporation announced today ... M. D. Anderson Cancer Center of the first patient ... E fficacy) Phase 2 pivotal trial ... (AML). AC220 is a novel, orally available, potent ... as a FMS-like tyrosine kinase-3 (FLT3) inhibitor. The ...
Breaking Biology Technology:Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5
... Will Offer a Personal Health Record and ... ,First Puppy, Healthy and Kissably Sweet at ... MMR Information Systems, Inc. (OTC Bulletin Board: ... MyMedicalRecords, Inc. (collectively, "MMR") provides consumer-controlled Personal ...
... Ga., March 27 ArunA Biomedical, Inc., announced ... hMC(TM) human mesenchymal progenitor cells commercially available to ... from pluripotent human embryonic stem cells, ArunA,s hMC ... of mesenchymal cells in a feeder free monolayer ...
... published the company,s Annual Report 2008. The report is ... Bavarian Nordic,s revenue for the year ... of DKK 183 million, which was in line with ... and cash equivalents stood,at DKK 796 million. For 2009, ...
Other Biology Technology:MMR and Dancing Paws to Participate in Joint Sales Effort to Provide Personal Health Records for Pets 2MMR and Dancing Paws to Participate in Joint Sales Effort to Provide Personal Health Records for Pets 3MMR and Dancing Paws to Participate in Joint Sales Effort to Provide Personal Health Records for Pets 4ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Mesenchymal Cells 2Bavarian Nordic Publishes its Annual Results 2008 2Bavarian Nordic Publishes its Annual Results 2008 3Bavarian Nordic Publishes its Annual Results 2008 4Bavarian Nordic Publishes its Annual Results 2008 5Bavarian Nordic Publishes its Annual Results 2008 6Bavarian Nordic Publishes its Annual Results 2008 7
(Date:12/14/2009)... 14 MODA Technology Partners, a global ... and product testing for the Pharmaceutical industry, today ... company,s third generation mobile data acquisition platform. The ... further automate their regulated manufacturing processes. ,, ... Fully-Configurable Test Methods: Each test ...
(Date:12/13/2009)... Yale University researchers has used nanosensors to measure ... time. Their findings, which appear December 13 in ... , could dramatically simplify the way physicians test ... , The teamled by Mark Reed, Yale,s ... and Tarek Fahmy, an associate professor of biomedical ...
(Date:12/11/2009)... PAAs consumer demand for premium fruit increases, growers ... to market. And to boost their bottom line, ... can increase fruit quality while reducing labor costs. ... growers to produce larger, healthier fruit, is among ... significant impact on fruit production overhead, and, ultimately, ...
Breaking Biology News(10 mins):MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2Scientists use nanosensors for first time to measure cancer biomarkers in blood 2Horizontal string trimmer reduces labor costs, increases peach size 2Arcadia Resources Announces Webcast of its Fiscal 2009 Fourth Quarter and Year End Conference Call 48847 1Arcadia Resources Announces Webcast of its Fiscal 2009 Fourth Quarter and Year End Conference Call 48847 2Forterus Inc Treatment Centers Serving Middle Class 3B Rapid Growth Detailed in Paul Howarth Interview 48844 1Forterus Inc Treatment Centers Serving Middle Class 3B Rapid Growth Detailed in Paul Howarth Interview 48844 2Parents In Wisconsin Can Now Test Their Children For Lead Exposure Using Saliva 48843 1Parents In Wisconsin Can Now Test Their Children For Lead Exposure Using Saliva 48843 2Parents In Wisconsin Can Now Test Their Children For Lead Exposure Using Saliva 48843 3Parents In Wisconsin Can Now Test Their Children For Lead Exposure Using Saliva 48843 4
... UK National Stem Cell Network Annual Science Meeting in ... work to investigate a mechanism that normally drives adult ... colleague Owen Sansom from the University of Glasgow, he ... crucial gene called Apc is lost or damaged, then ...
... e-Smart(R) Technologies,Inc. (Pink Sheets: ESMT); ("e-Smart" ... Smart Technologies, Inc., (IVI) (hereinafter, collectively,the "Company") ... last month by,IDsmart LLC, in the United ... Francisco Division, Case No. 3:06cv5528MHP, that IDsmart,admitted ...
... Society for Horticultural Science (ASHS) will convene its ... Florida. This conference will feature more than 900 ... horticultural science. Expected attendance will be more than ... , This year,s conference opens on Monday, July ...
Other Biology News:Stem cells and cancer: cancer pathways that also control the adult stem cell population 2IDsmart Admits in Court Document That e-Smart's Technology was Used to Develop IDsmart's Smart Card 2IDsmart Admits in Court Document That e-Smart's Technology was Used to Develop IDsmart's Smart Card 3American Society for Horticultural Science Annual Conference 2
... from the SMZ line is a Greenough stereomicroscope ... testing. It is available with a choice of ... space-saving compact base (N2GG). This microscope can be ... projector all at the same time giving you ...
This is a PYREX replacement Allihn condenser with a 34/45 inner joint on the bottom for the No. CLS3840-S 125mL extractor system. The tubulation O.D. on the condenser is 10mm....
... UNIchip AV-400 contains 400 unique ... nitrocellulose-coated glass slide. The proteins, all ... Ontology classification, are arrayed in quadruplicate ... and a specific chip layout guarantee ...
... Sub-Plates are E.Coli glycerol stocks contained in ... 50 cDNA clones with approximately 5,000 clones ... a master plate well, the corresponding subplate ... to identify the positive well(s). Cells from ...
Biology Products: